Altis is a Triangle biotech firm that provides a critical gut testing platform for drug discovery companies. This platform allows them to validate that drugs in development do not negatively impact the increasingly critical gut-health.
The Triangle Tweener Fund strategy is to build an index – smaller investments in a relatively large number of companies. At the current fund size this translates to 10-15 investments a quarter, or 40-60 a year. If you’ve been involved with traditional venture funds (picking winners) this pace seems impossible. Trust us, it’s not easy, but it’s definitely possible and the opportunity is there.
